Studies have revealed that Hsp90β, rather than Hsp90α, is notably overexpressed in the hepatocytes of individuals with nonalcoholic fatty liver disease (NAFLD) and diet‐induced obese (DIO) mice [136]. Here, HSP90AB1 is linked to metabolic dysfunction-associated steatotic liver disease.